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Abstract
Advanced paternal age (APA) is related to various genetic conditions, behavioral
disorders, and adverse pregnancy outcomes. Since the publication of ACMG’s practice
guidelines on APA in 2008, much has been learned about the causes of paternal age
effect (PAE) mutations and their clinical implications. However, no guidelines exist to
refer these high-risk pregnancies to prenatal genetics care, nor are effective screening
techniques presently available. As such, many patients are not fully-informed about the
risks to their pregnancies due to possible APA effects, and neither are are the men who
have fathered these pregnancies.
Our findings support that limited APA principles are being disseminated into the
general population. Additionally, prenatal patients of advanced maternal age (AMA) and
their partners favor the fathers of pregnancies as important decision makers, second only
to the mothers. Based on current knowledge of APA risks and molecular mechanisms, as
well as our study findings, we support a collaborative effort to address the shortcomings
of current prenatal genetic counseling procedure in its discussions of APA. The approach
to rectify this discrepancy in prenatal genetic counseling should include a revisit of the
2008 ACMG guidelines concerning APA as well as research efforts directed toward the
future goal of providing inclusive genetic counseling for men of APA and the
pregnancies they father.
Keywords: advanced paternal age, paternal age effect, advanced maternal age, decision
making, prenatal genetic counseling
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Chapter 1: Background
A 2013 study conducted in Taiwan documented the clinical care for a family who was
referred to prenatal genetic counseling due to maternal age and because of a previous
child diagnosed with osteogenesis imperfecta (OI) (Chen et al., 2013). Following her
diagnosis, a frameshift mutation was identified in the daughter, an insertion in the fiftysecond exon of COL1A1. The expectant parents were ages thirty-seven years (patient)
and forty-four years (partner). The curious aspect of this case is that the diagnosis of
autosomal dominant OI type III seen in the couple’s eighteen-month-old daughter had
recurred in the patient’s current pregnancy. Neither parent was affected, nor was the
couple’s three-year old son or the patient’s two older children from a previous
relationship. Based on the prenatal diagnosis, the couple decided to terminate the
pregnancy at twenty-three weeks gestation. Upon analysis for gonadal mosaicism, a
causative germline mutation was identified in the paternal line (Chen et al., 2013).
This incidence of recurrent OI type III warrants several questions. First, what
mechanism(s) explain the repetition of a de novo mutation in the paternal germline?
Second, what influence might the father’s age at conception have on recurrence of a
dominant disorder? Other studies have documented increased incidence of male gonadal
mosaicism associated with increased age in other dominant disorders as well, including
Hutchinson-Gilford progeria syndrome (D'Apice, Tenconi, Mammi, van den Ende, &
Novelli, 2003; Eriksson et al., 2003) and achondroplasia (Giudicelli et al., 2008). Third,
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what factors contribute to a couple’s decision to continue or not with the pregnancy?
Finally, how might genetic counseling be beneficial to couples in this type of situation,
and what information should be relayed to them?
The case above is but one example of increased occurrence of dominant disorders
in individuals whose fathers were aged forty years or older at the time of conception,
which is termed advanced paternal age (APA). According to the Centers for Disease
Control and Prevention, 3,952,841 births were registered in the United States in 2012. Of
these births, babies were born to fathers of APA at a rate of approximately 39/1000
(Martin, Hamilton, Osterman, Curtin, & Mathews, 2013). This included a 2% increase
for fathers aged 40-44 over births in 2011 and a 4% increase for fathers aged 45-49 over
births in 2011; births to fathers aged 50 and above remained comparable to those in 2011
(Martin et al., 2013).
Multiple studies have shown higher risks for behavioral and genetic disorders,
chromosomal conditions, and congenital birth defects in pregnancies with fathers of APA
than with younger fathers (Wiener-Megnazi, Auslender, & Dirnfeld, 2012; McGrath et
al., 2014). Wilhelm Weinberg may have been the first to document in 1912 his suspicion
about the relationship between paternal age and the risk for a dominant disorder,
specifically achondroplasia. His clinical notes were confirmed decades later by L.S.
Penrose (Thacker, 2004).
Saha and colleagues found children of APA fathers to be at an increased risk for
impairments in cognitive development when assessed at multiple ages during childhood,
when compared with children whose mothers were of advanced maternal age (AMA),
defined as age thirty-five years or older at the time of conception (Saha et al., 2009).
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Others have shown an increased risk for behavioral disorders such as autism spectrum
disorder (Durkin et al., 2008; Puleo et al., 2012) and schizophrenia (Sipos et al., 2004).
A cohort study of individuals born over a six-year period in the 1980s showed that
children born to fathers aged forty years and older were at a 5.75 times increased odds
ratio to develop autism spectrum disorder (Reichenberg et al., 2006).
As for paternal age and pregnancy outcome, the American College of Medical
Genetics and Genomics (ACMG) guidelines estimate that genetic mutations contributing
to disease onset for eighty-six examined congenital anomalies occur 20% more
frequently in APA pregnancies than in pregnancies that have younger fathers (Toriello &
Meck, 2008). Green et al. found increased risk for certain types of multifactorial birth
defects in children of APA fathers (Green et al., 2010). The anomalies that showed
significant linear correlation with APA were cleft palate, diaphragmatic hernia,
obstruction of the right ventricular outflow tract, and pulmonary valve stenosis (Green et
al., 2010). In a study in British Columbia, McIntosh, Olshan, and Baird (1995) found
increased risk for open neural tube defects, congenital cataracts, pyloric stenosis, and
upper limb reductions in newborns of fathers with APA. They reported higher incidence
of Down syndrome as well, occurring more than twice as frequently in fathers who were
fifty years or older at the time of conception than in fathers who were in their mid- to late
twenties (McIntosh, Olshan, & Baird, 1995). In all of these studies, the separate
influence of AMA was carefully controlled.
Research has shown an increase in pregnancy loss for fathers who fall into the
advanced age category. A two-year cohort in Denmark gave a cautious estimate that the
risk of miscarriage begins to increase steadily starting at a paternal age of forty-five
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years, with a two-fold risk for fathers who are age fifty and above (Nybo Andersen,
Hansen, Andersen, & Davey Smith, 2004). A 2005 study also showed a strong
correlation between APA fathers and miscarriage due to chromosomal abnormality, with
a significant risk increase for first trimester losses (Slama et al., 2005). The causes of
chromosomal aberrations in the paternal germline include increased nondisjunction,
acentric chromosomal fragments, and complex radial figures possibly resulting from
chromatin damage (Sartorelli, Mazzcatto, & de Pina-Neto, 2001).
Goriely and Wilkie published an analysis in 2012 of the evolving understanding
of the correlation between paternal age and genetic disorders, which is termed the
“paternal age effect,” or PAE (Goriely & Wilkie, 2012). In their considerations, a
disorder is determined to have a PAE if it matches three criteria: (a) there is an extreme
bias in paternal origin for mutations; (b) the age of fathers of affected children is on
average more than two years older than the general population’s typical fathering age;
and (c) a high de novo mutation rate for specific mutations in the paternal germline has
been established (Goriely & Wilkie, 2012). By their criteria, nine conditions caused by
point mutations in various genes were analyzed: four craniosynostosis disorders (Apert,
Crouzon, Pfeiffer, and Muenke syndromes); two skeletal dysplasias (achondroplasia and
thanatophoric dysplasia); two neuro-cardio-facial-cutaneous syndromes (Costello and
Noonan syndromes); and multiple endocrine neoplasia types 2A and 2B.
Goriely and Wilkie’s analysis related these PAE disorders to a molecular
phenomenon in the paternal germline. For the nine conditions described above, they
noted that mutations in the causative genes have also been related to tumor formation in
somatic tissues. Mutations in some of these genes are linked to the formation of
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spermatocytic seminomas in the spermatogonial stem cell line, which are precursors for
sperm formation (Goriely & Wilkie, 2012). In particular, spermatocytic seminomas are
more commonly found in the testes of older men. The authors therefore theorized that
mutations in these genes undergo positive selection in the paternal germline over time in
a process akin to oncogenesis, promoting their increased prevalence in the sperm of older
men, which would correlate to the higher incidences of these disorders in pregnancies
with APA fathers (Goriely & Wilkie, 2012). This concept, which has been termed selfish
spermatogonial selection (Goriely, McGrath, Hultman, Wilkie, & Malaspina, 2013), is
supported in numerous observations by various investigators (Kong et al., 2012; Lim et
al., 2012; Qin et al., 2007).
Goriely and colleagues (2013) described a common molecular denominator on a
cellular level for selfish spermatogonial selection. PAE genes are clustered within a
single pathway: the receptor tyrosine kinase/RAS (RTK/RAS) signaling cascade (Goriely
et al., 2013). This pathway is responsible for controlling proliferation and differentiation
during spermatogenesis. Because of the strong pathogenic selection these mutations
cause within testes and the lethal or deleterious effects of many de novo mutations on the
RTK/RAS pathway, many PAE-associated mutations are unlikely to have a long-term
disease burden on the general population (Goriely et al., 2013). However, they propose
that many selfish mutations with a weaker selective advantage are predicted to cause less
severe phenotypes (e.g., variants with low/varying penetrance or susceptibility). The
difference with these mutations is that these milder PAE mutations are a potential
contributing source for heritable variations and could increase the genetic burden of
common diseases in the general population (Goriely et al., 2013).
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Genome-wide association studies (GWAS) have identified single nucleotide
polymorphisms (SNPs) around these genes which are thought to increase risk for
multifactorial disorders, ranging from cancer to behavioral disorders such as
schizophrenia (Goriely & Wilkie, 2012). In addition, Perrin and co-authors proposed
epigenetic regulation as another probable cause for the relationship between paternal age
and schizophrenia (Perrin, Brown, & Malaspina, 2007). Environmentally-induced
variation in paternal epigenetic factors may have transgenerational consequences as well
(Curley, Mashoodh, & Champagne, 2011).
With current working knowledge of potential explanations for PAE disorders, one
may consider the appropriate methods by which counseling for APA risks could be
developed and applied clinically in the prenatal setting. As a point of comparison, the
prenatal care offered for AMA pregnancies reveals potential parallels for prenatal
screening and diagnosis in APA pregnancies. There are four major areas of contrast
between the care for AMA pregnancies and the care for APA pregnancies in prenatal
genetics: established referral procedures, counseling protocols to incorporate
comprehensive risk education, a counseling model to educate all parties contributing to
pregnancy risk, and the understanding of who remains the primary figure in fullyinformed pregnancy decision making for genetic testing.
The strengths of today’s prenatal care includes screening and diagnostic testing
for possible chromosomal and genetic conditions, typically including genetic counseling
to inform the patient about the pregnancy’s risks for certain conditions. This has resulted
from professional societal guidelines such as the American Congress of Obstetricians and
Gynecologists (ACOG) practice guidelines outlining recommendations for prenatal
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screening and testing (ACOG, 2007). From guidelines such as these, prenatal genetic
counseling has grown to offer information on specific risks related to AMA, including
options for screening and testing. The education that is available to prenatal patients of
AMA through the genetic counseling process is aimed at fully informing the patient so
that she can make an autonomous decision about which screening and/or testing is
appropriate for her individual pregnancy. In contrast, these driving forces are not
typically in place for fathers of APA for their partners to be counseled and fully informed
about today’s knowledge of the risks of PAE and implications of the multiple conditions
that may result.
When women of AMA are counseled during pregnancy about their age-related
risks for genetic disease, it is most often in reference to the risk of aneuploidy, defined as
abnormal chromosome number. Aneuploidy conditions may be the result of an error in
meiosis known as nondisjunction, where the chromosomes fail to separate equally during
gamete formation, leading to abnormal chromosome numbers in gametes. If these
gametes result in successful fertilization, the developing embryo will have an aneuploidy
condition. Increased risk of aneuploidy conditions associated with AMA include
Trisomy 21 (Down syndrome), Trisomy 18, Trisomy 13, and sex chromosome
aneuploidies such as Klinefelter syndrome (47,XXY), and Triple X syndrome (47,XXX).
While nondisjunction can occur in both sperm and eggs, the process has been more
commonly associated with female gamete formation (Chiang, Schultz, & Lampson, 2012;
Hassold & Hunt, 2001), with the risk for meiotic error increasing as a pregnant mother’s
age increases.
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As a result of potential aneuploidy conditions, a numerical cutoff risk
(approximately 1 in 300) has been established by medical professionals to designate
pregnancies at higher risk for chromosome abnormalities. This cutoff is based on the
approximate risk for miscarriage due to complications from the amniocentesis procedure,
which is the key technique to diagnose aneuploidy conditions prenatally. Studies have
shown that this cutoff risk is also the estimated frequency of aneuploidy conditions in
children of women who were 35 years of age at the time of delivery (Morris, Wald,
Mutton, & Alberman, 2003), described commonly as advanced maternal age (AMA),
with increasing maternal age correlating with higher risk for chromosomal conditions.
The standard of care for AMA patients for many years has included referral to a
genetic counselor who educates them about their risks and informs them about various
screening and testing options (Rubin, Malin, & Maidman, 1983), which then leads to
individual decision-making about pregnancy testing and management. Because of the
availability of effective screening and diagnostic options for aneuploidy testing, these
referrals are made with high confidence in the quality of care given to patients. In 2007,
the American Congress of Obstetricians and Gynecologists (ACOG) issued a revised
Practice Bulletin (#77) stating that all women of any age should be offered both prenatal
screening and prenatal diagnostic testing for aneuploidy (ACOG, 2007).
Diagnostic testing is performed through chorionic villus sampling (CVS) or
through amniocentesis; both are more than 99% accurate for detecting chromosome
aneuploidy and can be used to test for other potential genetic conditions, as well. These
types of prenatal diagnostic testing carry an inherent risk of miscarriage. Therefore,
patients often choose screening tests for information about their levels of increased
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chance of aneuploidy before considering an invasive procedure (e.g., CVS or
amniocentesis) for prenatal diagnosis. Screening options include measurements of
biomarker levels in maternal serum, as well as ultrasound imaging. Most recently,
noninvasive prenatal screening (NIPS) of cell free placental DNA in the mother’s blood
has been shown to have levels of sensitivity and specificity approaching those achieved
by diagnostic testing for chromosome aneuploidy (Devers et al., 2013). After educating a
patient on AMA risks and also on available testing options, the counselor facilitates the
patient’s decision making regarding her pregnancy care.
In stark contrast, the management of APA pregnancies differs critically from the
care of AMA pregnancies in several ways. First, no established professional guideline
exists for APA pregnancies to be referred to genetic counselors specifically for APA.
The ACOG committee opinion on APA was withdrawn in 2008. A single ACMG
guideline outlines what prenatal counselors should discuss with patients when APA is a
potential risk factor and specifically notes the increased risks for certain dominant traits
as well as for some birth defects and behavioral disorders. The use of ultrasound to
monitor for problems with fetal development is recommended (Toriello & Meck, 2008).
Specifically because no guideline exists recommending that APA be a referral
indication for genetic counseling and possible indication for screening for prenatal
disorders, many APA pregnancies are likely not being properly counseled or evaluated
for PAE. This overriding challenge for referral of APA pregnancies prevents the
information from being widely known and acted upon through prenatal screening and/or
diagnostic testing. In fact, the frequency at which patients in the APA category are being
“missed” is difficult to pinpoint. However, a reasonable estimation of these cases can be
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made based on the frequency of APA births. According to the work of Martin and
colleagues (2013), the birth statistics in the United States for 2012 demonstrate that APA
births occur at approximately 39/1000 live births, and AMA live births occur at an
approximate rate of 148/1000 (Martin et al., 2013). This roughly equates to one APA
birth for every four AMA births. While these numbers are not representative of AMA
and APA pregnancies that did not carry to term, a reasonable expectation would be that
total APA and AMA pregnancies occur at a comparable rate. Therefore, APA
pregnancies would account for approximately 20% of age-related indications for prenatal
genetic counseling if established referral protocols were in place. However, without
these necessary guidelines, a significant proportion of high risk pregnancies are likely not
receiving full risk information during prenatal genetics care.
A second challenge arises from the logistics involved in PAE sessions,
specifically the complexity of information and time constraints, which may place a
limitation upon genetic counseling for cases of APA. In addition, because of the limited
feasibility in current screening and testing methods for the numerous conditions that are
associated with APA, a potential issue arises in that the counselors discussing these risks
with patients and their partners may feel they are violating the health care creed of
primum non nocere (first, do no harm) by causing undue anxiety for counselees,
especially given the limited feasibility in screening and testing methods for these
conditions. This professional reservation, in turn, may influence how patients are
educated and, ultimately, lack of accurate information could impact patient autonomy in
decision making.
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This hesitation on the part of genetic counselors has also been observed in the
realm of genetic counseling for psychiatric illness. The wide array of risk estimates
partnered with the unavailability of testing options for behavioral disorders produces
among counselors the tendency to assume that these ranges are not useful and should not
be discussed thoroughly. This assumption is then projected onto clients that they, too,
would find risk ranges meaningless, when in fact they desire whatever information
genetic counselors can provide (J. Austin, personal communication, April 11, 2014;
Monaco, Conway, Valverde, & Austin, 2010; Hippman et al., 2012).
Prenatal testing options for genetic conditions related to PAE will likely become
available to patients in the near future with advancements in sequencing and screening
techniques, but this does not speak to how patients and their partners are currently being
counseled. Hence, an issue worthy of exploration is to inquire of current patients about
the level of detail parents may desire about APA information and health consequences of
PAE, including options available for screening, diagnosis, and treating such conditions.
A third consideration for genetic counselors is how the current AMA-based
counseling model does not incorporate the equipping of APA men with their genetic risk
education for their future planning. This in turn affects the facilitation of autonomous
decision making, a central tenet to counseling technique.
A third challenge for genetic counselors is how to best educate the AMA/APA
parent(s) to ensure that that she/he/they are fully informed about these potential
conditions in order for the patient/partners to make a fully informed decision about
screening and testing during pregnancy. The responsibility of the counselor is to ensure
that the patient leaves the session well-informed to make the best personal decisions
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regarding her pregnancy care (Weil, 2000, p. 145). This is of particular importance to the
male parent also, in that he should become aware of any possible risks to a pregnancy due
to his age, given that he may be fathering children in the future with the same or another
partner.
Much can be learned for educating the APA parent(s) from the current high
standards of AMA counseling. While the standard AMA genetic counseling session
follows a fairly standard agenda of issues to be covered, minimal information has been
reported about how effective the counseling is in educating the AMA patient. After
many years, the public is generally aware that older age of a pregnant female parent can
confer a higher risk of aneuploidy in the fetus. Finding out about general knowledge of
APA and especially of PAE and health implications to the offspring in a survey setting of
AMA patients could serve as a preliminary baseline of information about the general
patient’s knowledge of PAE.
As an additional consideration for fully-informing prenatal patients, various
individuals’ understanding of numbers and how to apply them (i.e., numeracy) can
impact their healthcare decisions, including within genetic counseling. If a patient has
low numeracy, she is less likely to choose the most effective treatment and accurately
assess the level of benefit of treatment (Lipkus & Peters, 2009; Sheridan, Pignone, &
Lewis, 2003). For example, the genetic counselor must explain the various testing
options with detection rates, accuracy measures, limitations, and associated benefits and
risks (Pergament & Pergament, 2012). This aspect of counseling requires the counselor
to evaluate patient health literacy and numeracy in order to convey genetic risk in a way
that is best understood by each patient (Lea, Kaphingst, Bowen, Lipkus, & Hadley,
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2011). Therefore, when considering concepts like PAE, identification of the preferred
numerical risk representations of women and men in relation to healthcare may improve
patient understanding in prenatal settings and promote better decision making in some
patients/couples, as well as reduce the chance for undue anxiety. The benefit of this type
of information for patients may be ascertained through the risk information they desire to
be given and by the ways in which they make decisions regarding pregnancy care.
Therefore, assessing patients’ understanding of health risks associated with advanced
parental age may prove helpful to enhance risk comprehension and maximize retention
post-counseling in discussions of APA-related conditions. This evaluation could include
determining knowledge of basic genetic principles regarding advanced parental age, as
well as by identifying the numerical risk formats that are most preferred by patients and
partners.
Additionally, the possible desire of patients and their partners to have risk
assessment based on their status as a couple or upon each individual’s contribution is
unknown. Understanding the impact of PAE risk on decision-making processes may
demonstrate the desire of patients and partners to be counseled by healthcare
professionals concerning both AMA and APA risks.
The risk in making decisions for a not fully informed patient may include
unpreparedness to handle challenges that come with having an affected child. As an
example, Jiminez and colleagues found that parents with low health education and
understanding experienced more confusion over early intervention (EI) referrals for their
affected children (Jimenez, Barg, Guevara, Gerdes, & Fiks, 2013). In addition, many of
these parents felt that physicians did not adequately explain the purpose and methods of
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EI (Jimenez et al., 2013). Therefore, the fully-informed prenatal patient relies upon the
knowledge and practices of her healthcare providers. Additionally, if patient education is
essential to equipping parents to plan and care for their families, which is addressed by
the core definition of genetic counseling, this suggests that the role of genetic counselors
is to help patients/parents adapt to the diagnosis of a genetic condition (Resta et al.,
2006). Based upon current practices for APA pregnancy care and their insufficiency to
address the current understanding of PAE risks and mechanisms, this core principle to the
discipline of genetic counseling is violated.
Another consideration for the impact of relaying PAE risk assessments to a fullyinformed patient is the decision-making process of the patient, often with the input of her
partner. Several psychosocial facets of relationships influence the way individuals
perceive and interpret risks and testing options (Weil, 2000, p.39-46). In regards to the
decision-making processes of patients and partners together, though, a literature review
yields little information about role of couple dynamics in healthcare decision making,
particularly in relation to prenatal care. However, some study findings may have
implications for counseling couples in prenatal settings. In 1996, Cairns, Shackley, and
Hundley published an article examining women’s preferences for carrier screening for
cystic fibrosis (CF) and found that, depending on how screening options are presented to
patients, their screening preferences may change. Their results suggest that patients
desire to know their partners’ genetic risk contributions to pregnancy, and that patients’
primary preference, if they choose to have prenatal screening, may be to have genetic
screening performed in tandem with their partners (Cairns, Shackley, & Hundley, 1996).
Therefore, the preferred simultaneous screening to assess the couple’s risk for an affected
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child may also be found favorable to patients in other prenatal care scenarios, as well,
such as in the provision of age-related risk assessments.
In a recent study, Shiloh et al. assessed adult participants’ attitudes about
multiplex genetic testing for their personal health risks. The study’s reported goal was to
learn how preexisting attitudes about common adult-onset diseases would influence an
individual’s desire to undergo genetic testing for those diseases (Shiloh, Wade, Roberts,
Hensley Alford, & Biesecker, 2013). Of the 294 adult participants, 140 opted to have
multiplex testing completed for eight common adult-onset diseases. However, 78% of
those who chose testing elected not to receive information regarding at least one of the
diseases included in the panel (Shiloh et al., 2013). If the results of this study were to be
found applicable to prenatal decision making, then prenatal patients who were offered a
multiplex test for conditions associated with PAE may best be offered the option to select
which genetic susceptibilities are reported to them for consideration in decision making.
Recently this opt-out approach has been applied to NIPS procedures. In October
2013, Sequenom® Laboratories added to their MaterniT21™ Plus test a series of
chromosome abnormalities with an opt-out option for reported results. Now, in addition
to their aneuploidy analyses of chromosomes 13, 18, 21, X, and Y (which are reported to
all patients), Sequenom® offers the reporting of aneuploidies for chromosomes 16 and
22, as well as several microdeletion syndromes: 22q11.2 deletion syndrome, Angelman
and Prader-Willi syndromes, Cri-du-chat syndrome, and 1p36 deletion syndrome
(Sequnom® Laboratories, 2014). These added conditions are rarer than the aneuploidy
conditions and have various intellectual, behavioral, and physical ramifications. For this
panel expansion, the laboratory has afforded patients the option to choose not to have the
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additional results reported (Sequenom® Laboratories, 2014). Additional rare conditions
are expected to be added to this screening periodically in the coming months.
In summary, the effect of APA on genetic risks in pregnancy presents several
challenges for genetic counseling, some of which are similar to those which were
addressed in order to provide the best care for AMA pregnancies:
a. The absence of professional societal guidelines that direct the referral of APA
pregnancies as an indication for prenatal screening and testing, including
genetic counseling;
b. The equipping of genetic counselors with current information and education to
effectively counsel these parents;
c. The necessity of patient education about APA and PAE such that they
understand the possible implications and potential risks to their pregnancy in
order to make fully informed decisions about screening, testing, and
pregnancy management; and
d. The ways in which patient decision making may or may not change in a
setting where additional risks and different medical concerns due to the effects
of APA are fully discussed.
First, differences have evolved in the way parental age is addressed with each
gender group. The care for expectant women of AMA has long been studied with
reliable screening and diagnostic techniques available. In addition, specific guidelines
for referral and practice have been established to assist couples as they make decisions
regarding the care for their pregnancies. For APA pregnancies, however, a
recommendation for referral to genetics for the advising of increased genetic risks due to
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APA is not supported by multiple medical societies. Additionally, when APA
pregnancies are seen for genetic risk assessment, ACMG’s guidelines published in 2008
may not provide a sufficient strategy for counseling since much has been discovered
about PAE in more recent years. Also, no effective screening technique for PAE-related
conditions currently exists beyond the minimal potential benefit through ultrasonography.
Therefore, counselors do not have tools in place to provide patients reassurance of a
lowered risk assessment or confirmation of an empiric risk estimate.
Another consideration lies in understanding what education about PAE, if any,
prenatal patients and their partners wish to have. The benefit of this type of information
for patients may be ascertained through the risk information they desire to be given and
by the ways in which they make decisions regarding pregnancy care. Therefore,
assessing patients’ understanding of health risks associated with advanced parental age
may prove helpful to enhance risk comprehension and maximize retention postcounseling in discussions of APA-related conditions. This evaluation could include
determining knowledge of basic genetic principles regarding advanced parental age, as
well as by identifying the numerical formats that are most preferred by patients and
partners.
Additionally, the possible desire of patients and their partners to have risk
assessment based on their status as a couple or upon each individual’s contribution is
unknown. Understanding the impact of PAE risk on decision-making processes may
demonstrate the desire of patients and partners to be counseled by healthcare
professionals concerning both AMA and APA risks. The definition of a fully-informed
patient changes when considering the practice of counseling a couple on APA risks. In
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turn, the facilitation of autonomous decision making is complicated by the incorporation
of the father’s opinions regarding his risk contribution and the testing options that may
become available.
Because of the limited information concerning the implementation of genetic
counseling for PAE in relation to prenatal patient care, we have designed this study with
the intent to establish a foundation for addressing clinical concerns of prenatal risks from
APA. We hope to gain initial insight into how patients and their partners prefer to be
educated about prenatal risks associated with increased parental age, with a specific focus
on APA concerns, and seek their opinions about how they think they would react to
future pregnancy scenarios that are consistent with some APA conditions.
We hypothesize that our study will show that patients favor receiving more
thorough genetic counseling regarding APA risks, despite the current limitations of
effective screening tools available for conditions associated with APA. We will collect
responses about communications concerning risk assessment and their preferences. From
the data we generate, we hope to ascertain if we should offer more information about the
prenatal risks due to APA and how we might educate prenatal patients and their partners
concerning the known contributions of APA to genetic disease risks. We hope to open
discussion about incorporating APA education into a new “standard” of care for prenatal
parents by genetic counselors and other healthcare professionals and to promote
collaborative thinking and research to address current and upcoming issues with APA.
Our desire is that the findings of this study will foster the production of informed and
malleable clinical guidelines for inclusive genetic counseling on APA.
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Chapter 2:
The Paternal Age Effect: A Preliminary Study of Current
Challenges for Prenatal Genetics Care 1
2.1 Abstract
Advanced paternal age (APA) is related to various genetic conditions, behavioral
disorders, and adverse pregnancy outcomes. Since the publication of ACMG’s practice
guidelines on APA in 2008, much has been learned about the causes of paternal age
effect (PAE) mutations and their clinical implications. However, no guidelines exist to
refer these high-risk pregnancies to prenatal genetics care, nor are effective screening
techniques presently available. As such, many patients are not fully-informed about the
risks to their pregnancies due to possible APA effects, and neither are the men who have
fathered these pregnancies.
Our findings support that limited APA principles are being disseminated into the
general population. Additionally, prenatal patients of advanced maternal age (AMA) and
their partners favor the fathers of pregnancies as important decision makers, second only
to the mothers. Based on current knowledge of APA risks and molecular mechanisms, as
well as our study findings, we support a collaborative effort to address the shortcomings
of current prenatal genetic counseling procedure in its discussions of APA. The approach
to rectify this discrepancy in prenatal genetic counseling should include a revisit of the

1

Gunter AT, Walker P, Lipkus IM, and Toriello HV. To be submitted to Journal of Genetic Counseling.

19

2008 ACMG guidelines concerning APA as well as research efforts directed toward the
future goal of providing inclusive genetic counseling for men of APA and the
pregnancies they father.
Keywords: advanced paternal age, paternal age effect, advanced maternal age, decision
making, prenatal genetic counseling
2.2 Introduction
The effect of APA on genetic risks in pregnancy presents several challenges for
genetic counseling. The first challenge is the different medical concerns due to the
effects of AMA and APA. In AMA, aneuploidy conditions are most common, whereas
the types of genetic conditions associated with APA are primarily due to single gene
changes and chromosome aberrations (Sartorelli et al., 2001). APA conditions are also
more varied in their clinical courses and include behavioral disorders, genetic disorders,
chromosomal conditions, and congenital birth defects (McGrath et al., 2014; WienerMegnazi et al., 2012; Reichenberg et al., 2006; Green et al., 2010). In addition to the
different types of disorders more prevalent in APA pregnancies, the mechanisms that
promote the increased frequencies of genetic conditions differ between women and men:
the increased risk of nondisjunction in the eggs of aging women (Chiang et al., 2012;
Hassold & Hunt, 2001) versus the increased risk for de novo germline mutations, coupled
with positive selection, in aging men (Kong et al., 2012; Lim et al., 2012; Qin et al.,
2007). Additionally, evidence suggests that disorders associated with APA may increase
the genetic burden of disease in the population over time (Goriely et al., 2013).
Second, differences have evolved in the way parental age is addressed by gender
group. The care for expectant women of AMA has long been studied with reliable
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screening and diagnostic techniques available (Devers et al., 2013). In addition, specific
guidelines for referral and practice have been established to assist couples as they make
decisions regarding care for their pregnancies (Rubin et al., 1983; ACOG, 2007). For
APA pregnancies, however, a recommendation for referral to prenatal genetics services
for the advising of increased genetic risks due to APA is not supported by multiple
medical societies. Additionally, when APA pregnancies are seen for genetic risk
assessment, ACMG’s guidelines published in 2008 may not provide a sufficient strategy
for counseling because of newer discoveries about PAE in recent years. Also, no
effective screening technique for PAE-related conditions currently exists beyond the
minimal potential benefit through ultrasonography. Therefore, healthcare providers do
not have tools in place to provide patients reassurance of a lowered risk assessment or
confirmation of an empiric risk estimate.
A third challenge lies in understanding what education about PAE, if any, prenatal
patients and their partners desire. The benefit for patients in receiving education on
APA-related risks may be ascertained through the risk information they desire and by the
decision-making strategies they employ in regards to pregnancy care.
As another consideration, for effective genetic education, determining how
concepts can best be relayed to counselees is an important factor in equipping them for
making decisions. Therefore, assessing patients’ understanding of health risks associated
with advanced parental age may prove helpful to enhance risk comprehension and
maximize retention post-counseling in discussions of APA-related conditions (Lea et al.,
2011). This evaluation could include determining knowledge of basic genetic principles

21

regarding advanced parental age, as well as by identifying the numerical formats that are
most preferred by patients and partners.
Additionally, the possible desire of patients and their partners to have risk
assessment based on their status as a couple or upon each individual’s contribution is
unknown. Understanding the impact of PAE risk on decision-making processes may
demonstrate the desire of patients and partners to be counseled by healthcare
professionals concerning both AMA and APA risks.
In summary, the effect of APA on genetic risks in pregnancy presents several
complications for current counseling models in prenatal genetics, some of which are
similar to those which were addressed in order to provide the best care for AMA
pregnancies:
a. The absence of professional societal guidelines that direct the referral of APA
pregnancies as an indication for prenatal screening and testing, including
genetic counseling;
b. The equipping of genetic counselors with current information and education
about APA-related conditions and mechanisms of PAE to effectively counsel
these parents;
c. The necessity of patient education about APA and PAE such that they
understand the possible implications and potential risks to their pregnancy in
order to make fully informed decisions about screening, testing, and
pregnancy management; and
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d. The ways in which patient decision making may or may not change in a
setting where additional risks and different medical concerns due to the effects
of APA are fully discussed.
Because of the limited information concerning the implementation of genetic
counseling for PAE in relation to prenatal patient care, our group designed this study to
establish a foundation for addressing clinical concerns of prenatal risks from APA. We
hoped to gain initial insight into the desire patients and their partners to be educated
about prenatal risks associated increased parental age, with a specific focus on APA
concerns.
We hypothesized that patients favor receiving more thorough genetic counseling
regarding APA risks, despite the current limitations of effective screening tools available
for conditions associated with APA. Some couples may also desire that their risk be
communicated as a single estimate based on the couple’s combined risk contributions.
Findings can help illuminate if more information about the prenatal risks due to APA
should be offered, the appropriate content of the information (e.g., how we might educate
prenatal patients and their partners about known contributions of APA to genetic disease
risks), and plausible specific genetic counseling practice recommendations that can guide
genetic counseling services to prenatal patients and their partners of APA. We intend to
foster collaborative thinking and research to address current and upcoming issues with
APA. Our desire is that the findings of this study will promote the production of
informed and malleable clinical guidelines for inclusive genetic counseling on APA.
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2.3 Materials and Methods
2.3.1 Participants
This study was targeted to adult women and men in high risk pregnancy
scenarios, where at least one parent is of advanced parental age (35 years for women and
40 years for men). The following inclusion criteria were used:
a. Women presenting for prenatal genetic counseling who were 35 years or older
and/or whose partner was 40 years or older;
b. Men who were 40 years or older, presenting with their partners for prenatal
genetic counseling and/or whose partners were 35 years or older;
c. English speakers, due to limitations of written materials; and
d. Recognized competence to read and understand the written materials.
The following exclusion criteria were included for this study:
a. Individuals who were not proficient in English to an 8th grade reading level;
b. Individuals who did not meet the age specifications above;
c. Individuals whose reading comprehension was insufficient to understand the
survey information;
d. Individuals whom the Genetic Counselor considered to be emotionally unable
to participate based on extraordinary referral reasons (e.g., fetal demise or
severe fetal prognosis by ultrasound);
e. Individuals who were referred for preconception counseling (i.e., are not
currently pregnant); and
f. Individuals who were counseled by the primary investigator.
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A survey was distributed through a prenatal genetics clinic in Columbia, SC, to
eligible patients and their partners who met the aforementioned study criteria. The
survey was offered at the end of the genetic counseling session, and participants were
able to complete the survey in the waiting room or at home after the session. Surveys
were distributed over a four-month period from September 2013 through January 2014.
Surveys were received from participants until mid-February 2014.
The survey consisted of a series of statements for each participant’s consideration
to assess their understanding of risk contribution by each gender to future offspring, as
well as their opinions on pregnancy decision making within the couple dynamic.
Participants were also asked to consider scenarios for a hypothetical future pregnancy
where prenatal screenings are available for conditions associated with APA. Participants
were asked to indicate their theoretical desire to undergo various screening techniques in
order to provide risk information to them.
Answers were based on a Likert scale of agreement or disagreement with each
statement (1 = Strongly Disagree and 5 = Strongly Agree). Additionally, each subject
was presented with several representations of the same numerical value based upon the
common practices of the clinic and also on the findings of Grimes and Snively (1999).
Each participant was asked to identify the numerical representation she/he felt was most
easily understood when used to relay risk estimates. For the questions regarding future
screening techniques, participants were asked to comment on their motivations for
preferring one method over another.
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2.3.2 Statistical Analysis and Methods
Microsoft Office Excel 2013 software was used to identify frequencies and
percentages in responses. For quantitative analysis, Statistical Package for Social
Sciences (SPSS), version 22.0, was used after the data was transferred from Excel
spreadsheets to SPSS. Correlation studies using Spearman’s Rho analysis compared
demographic variables to the Likert-scale responses available for the five conditions
presented in the scenarios.
In addition, Fisher’s exact test was employed to determine if a dependency
existed between independent and dependent variables. For the survey portions regarding
advanced parental age concepts, numerical preferences, and decision-making preferences,
Fisher’s test compared participants’ responses to their demographic information, such as
their parental status (having children or not), for possible statistically significant
associations. Respondents’ answers to the Likert-scale questions regarding a future atrisk pregnancy were analyzed quantitatively for frequency, calculated as percentage of
total responses, regarding their decision to test or not to test for the proposed conditions.
Written responses to these same questions were then analyzed qualitatively using
grounded theory methods for identifying possible common themes about respondents’
reasons for making their individual decisions.
This study was approved by the Institutional Review Board of the Office of
Research Compliance, University of South Carolina, Columbia, in August, 2013.
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2.4 Results
2.4.1 Participants
Fifty-eight surveys were distributed to eligible subjects. Twenty-three of the
distributed surveys were completed and returned to the primary investigator for a
response rate of 40%. Study participants (N = 23) were organized by age, gender,
ethnicity, marital status, highest level of education, and status of having children prior to
their current pregnancy. These demographics can be found in Table 2.1. The ages of
participants ranged from 29-45 years old with an average age of 38 years (SD = 3.67).
All participants had obtained at least a high school-level education, and a majority (65%)
had had some college education or more. Individuals who indicated they had children
outside of their current pregnancy were asked to report how many they had. Reported
numbers ranged from one child to six children, and these participants had 2-3 children on
average, including their current pregnancy. We note that of the 23 total respondents, only
two were male.
2.4.2 Comprehension of Advanced Parental Age Concepts and Numbers
Questions concerning participant understanding of age-related genetic risks
revolved around three foci: how well participants retained information received through
AMA risk counseling, participants’ understanding of pregnancy risks associated with
APA, and participants’ preferences for risk communication based on a limited set of
numerical options.
For AMA-associated risks, most subjects (65%) agreed with the statement that a
baby’s risk to have Down syndrome is increased only by parents’ genetic information and
not by parental environment. Most respondents (87%) indicated understanding that a
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Table 2.1
Participant Demographics

mother who is 35 years or older at pregnancy has a higher chance to have a baby with
Down syndrome than a younger mother.
For APA-associated pregnancy risks, about one third (35%) of respondents
indicated agreement with the statement that a father older than 40 years at conception has
a higher risk of having a baby with Down syndrome. Figure 2.1 represents subjects’
understanding for the chances for Down syndrome in relation to genetics versus
environment, AMA, and APA. Forty-four percent of participants showed uncertainty
with the statement that older paternal age carries a lower risk of fathering a child who
will develop autism, suggesting that they do not know this information, while 57%
disagreed with the same statement, suggesting more were correct than the percentage
who did not know the correct answer.
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Figure 2.1 Respondents’ knowledge regarding Down syndrome risk factors.

Two questions reflected respondents’ preferred numerical format of conveying
risk information: a) Selection of a simple risk descriptor [options: 10%, 1/10, 1 chance in
10, or 10 chances out of 100]; and b) Comparative description of the chance for event
occurrence and event nonoccurrence (e.g. 10% chance of having the condition, and 90%
chance of NOT having the condition). Most respondents (78%) desired a percentage
(e.g., 10%) or a ratio (e.g., “1 chance in 10” for a condition to manifest). When asked
how they would prefer a medical professional to report chances for a serious condition
such as a heart condition, most (87%) preferred a ratio or a percentage for the event
occurrence or nonoccurrence (e.g., “10% chance of having the condition, and 90%
chance of NOT having the condition”). The dependence between respondents’
preferences in the first question was statistically significant in determining their
preferences in the second question (Fisher’s exact test, p = .006), which indicates that
respondents are likely to remain consistent in their preferred numerical format.
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Participants were also asked to indicate which of their previous responses would be their
choice overall (i.e., choosing a simply-stated percentage versus a percentage for the
condition and a percentage not to have the condition). Roughly 70% of respondents
indicated preference for being told both sides of a risk assessment.
2.4.3 Decision-Making Preferences During Pregnancy
Participants indicated their level of agreement with which individual should make
decisions regarding genetic testing during pregnancy: the patient, her partner, the doctor,
or the genetic counselor (see Figure 2.2). Twelve participants (52%) believed that the
mother should make final decisions regarding any genetic testing during pregnancy,
based upon four Likert-scale questions. Fourteen participants (61%) disagreed that the
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Figure 2.2 Participants’ favor towards each respective individual as the decisionmaker for genetic testing during pregnancy.

father should be the primary decision-maker for prenatal testing. About two-thirds of
respondents disagreed with the physician making the decisions (65%) and with the option
for the genetic counselor to make decisions about prenatal genetic testing (69%).
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Participants’ agreement with the mother as being primary decision maker for
prenatal genetic testing and disagreement with the father as primary decision maker using
Likert scale responses was shown to be statistically significantly correlated by
Spearman’s Rho analysis, r(21) = .422, p = .045. The distribution of participants’
responses can be found in Figure 2.3a. In comparison, however, there was not a
statistically significant correlation by Spearman’s Rho analysis between participants
preferring the mother as primary decision-maker for genetic testing compared with a
genetic counselor as primary decision-maker, r(21) = .056, p = .800. The distribution of
those responses can be found in Figure 2.3b.
When considering decision-making as a couple for prenatal genetic testing, 20 of
23 participants (87%) agreed with the statement that final decisions regarding prenatal
genetic testing should be based on the parents agreeing together on one testing option. In
addition, 21 of 23 participants (91%) believed that they would have the same opinions as
their partners regarding testing options. Participants’ responses were not statistically
significantly dependent on marital status (Fisher’s exact test, p = .308).
When asked who should make a final decision for prenatal genetic testing in the
event of a patient and her partner being unable to agree on an option, participants ranked
their preferences from among the patient, her physician, her partner, and her genetic
counselor (see Figure 2.4). Twelve of 21 respondents (57%) ranked the patient first in
making the final decision when the two are in disagreement, and Spearman’s rho analysis
showed a statistically significant correlation between ranking of the mother’s and father’s
decisions, r(17) = .589, p = .008. The correlation between ranking of the father’s choice
over the physician’s choice was negative and was also significant, r(17) = -.730, p < .001.
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Figure 2.3 Distribution of participants’ responses to preferring
maternal decision making for genetic testing versus paternal decision
making (a) and preferring maternal decision making versus genetic
counselor decision making (b).
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Figure 2.4 Participant priority rankings for the right to make genetic
testing decisions in the event that a patient and her partner do not agree on
an option together.

There was also a statistically significant and negative correlation in the rankings between
father’s choice and genetic counselor’s choice, r(17) = -.466, p = .044, but not between
rankings of physician’s choice and genetic counselor’s choice, r(18) = .371, p = .107.
2.4.4 Genetic Education Preferences Related to Parental Age Risks
Participants were asked about their desire to know all parental age-related risks.
For each question, approximately 70% favored education about all risks associated with
advanced parental age. The responses to these three questions were combined into a
composite score (Crohnbach’s α = .995) for statistical comparisons. Participants were
also asked to indicate a preference for risk assessment based upon each parent’s
individual contribution to age-related risk or for a single combined risk estimate for the
couple. Neither option was strongly favored over the other, as 44% preferred two
separate risk numbers, 48% preferred a combined risk estimate for the couple, and two
participants indicated a preference for both.
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2.4.5 Considerations for Potential Future Testing Options
Participants were given three scenarios for possible future pregnancies, asking
them to indicate if they would want screening in each scenario. For a potential maternal
blood test for genes associated with a higher risk of a child to develop autism, most
respondents (74%) indicated they would want this type of information in a future
pregnancy. Only one respondent indicated she definitely would not want this type of
testing. For a possible scanning test that could be offered in a future pregnancy to assess
higher risk for juvenile-onset seizures, 14 of 23 participants (61%) favored this type of
screening. For a maternal blood test that could detect potential learning problems for an
expected child, slightly over half of respondents (54%) favored this type of screening for
a future pregnancy. Figure 2.5 captures subjects’ favorability for each type of testing
proposed.
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Figure 2.5 Respondents’ favorability toward prenatal or screening for
conditions associated with APA.
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When offered ultrasound screening for features of genetic conditions associated
with parental age, 13 of 22 participants (59%) indicated a desire to know all possible
risks for their child prior to having the ultrasound conducted. The remaining nine
participants (41%) indicated a desire to only know specific risks to the baby after
ultrasound findings were reported. Participants’ preferences for receiving education
about genetic risks associated with parental age was not significantly associated with
their favorability toward any of the testing options proposed in the hypothetical future
pregnancy scenarios (Fisher’s exact test, p > .410 for each proposed testing option) or
with their parental status prior to their current pregnancy (Fisher’s exact test, p = .333).
Two investigators coded the responses of participants concerning their
motivations for favoring/disfavoring the various screening/testing tools proposed for
future pregnancies. Both coders came to the same conclusion that motivating factors for
respondents included the desire for risk-associated information, the potential influence
this information would have on decision making, and the effect on how the patient and/or
her partner could prepare for their child.
Eight respondents described their priority to receive risk-related information
regarding pregnancy. Their motivations included the following: “[It] would be better to
know than to not know;” “Knowing the test is available and not taking it is not an option
for me. I always want to know;” and “If I am at higher risk I want to know more details
if possible.”
For those who described preparedness as a key motivator, responses included
thoughts such as “[the ability] to prepare properly for the future and my child’s needs”
and “…to be informed of any condition that may affect my child, so that I can prepare
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myself if it comes to light.” When participants described the influence of age-related risk
screening as a key component in making decisions, some thoughts that were recorded
include: “I prefer to know all the risks my baby might be exposed to before deciding to
continue/terminate the pregnancy;” and “…I believe in making informed decisions in life.
It is important to know all the facts to make sound decisions.”
Other participants noted specific conditions that would determine their desire to
proceed with screening or testing. These included the cost of the testing and also the
accuracy of the technology to detect a specific condition. Reasons respondents
disfavored testing included a lack of family history for the condition, the plan to have no
more children after their current pregnancy, and disinterest in a risk percentage (i.e., the
preference for definitive results only). One participant noted her motivation for screening
as a desire to maintain a sense of control following a previous loss:
I only chose [the testing option] because I had a stillborn baby last year,
and it makes me feel out of control and [have] constant worry, so having
lots of tests (which I appreciate) makes me feel in control or able to do
something and alleviates my remaining guilt about my baby, even though
I’m not supposed to have any. If I’d not had this experience I would not
answer yes; I would have no tests and no ultrasound as I did before my
[previous] daughter’s blissful birth.
2.5 Discussion
2.5.1 Genetic Education on Parental Age Risks
The goal of our study was to establish a foundation for addressing the clinical
concerns of prenatal risks from APA. Our first aim was to understand counselees’
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understanding pertaining to concepts that are currently discussed in prenatal genetic
settings, specifically centered on genetic education and risk assessment. Our results
demonstrated that the majority of participants retained basic information discussed during
their thorough counseling of AMA-related risks, given that the majority of respondents
correctly identified each genetic education concept pertinent to AMA that was proposed
in the survey.
We also desired to briefly assess how well APA concepts have permeated the
general population’s knowledge. Approximately half of respondents indicated an
understanding of increased risk for autism with APA, but most did not understand
increased risk for Down syndrome with APA. While participants may have guessed on
these questions, a possible explanation is that this knowledge is becoming (somewhat)
integrated among lay audiences, especially represented in this highly educated sample of
respondents (65% with college level education). Therefore, a warranted question is that
if the general population is aware of some risks associated with APA, why are these risks
not being discussed in clinical genetic settings to enhance understanding and correct
misconceptions (e.g., only 35% of respondents comprehended an increased risk for Down
syndrome in APA fathers)?
Questions dealing with risk presentation were targeted to understand which
representations of numerical values are preferred on an individual basis. Respondents’
preferences were assessed more than once, and upon each assessment, percentages and
verbal descriptions of rates such as “___ chance(s) out of ten chances” were preferred by
a majority. Additionally, the presentation of the chances for a condition’s nonoccurrence along with the chances for the condition’s occurrence was favored, which
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further supports the concept of presenting balanced information during genetic
counseling sessions. Regarding genetic education preferences, a majority of participants
(70%) favored receiving education on all risks surrounding AMA and APA. This is an
area that warrants future research to yield more generalized opinions than those
represented in this small study focused in a specific geographical area.
2.5.2 Impact on Patient Autonomy in Decision Making
In prenatal genetic care, the mother’s decision is considered primary in decision
making by her healthcare professionals. The results of this study support that patients
and partners agree with this concept. While the majority of participants (91%) were
female, upon inspection of the two surveys contributed by male participants, one favored
the mother’s decision as primary and the father’s secondary, and the other considered the
patient’s and partner’s decisions as equally important. Given the effect APA/PAE
concepts will have on decision making, the incorporation of these additional risk factors
redefines what constitutes a fully informed and autonomous female patient.
In addition, the father of the pregnancy was favored by participants as the second
decision-maker in prenatal genetic testing decisions. Because of the high regard that
patients and their partners place on the opinions of the father regarding genetic testing, it
may be beneficial for genetic counselors to address parental age-related concepts with the
father counseled as a “patient” secondary to the mother. This is of particular importance
in regards to APA counseling because of the implications for any future pregnancies the
father may have, which may be with a different partner. By not adequately counseling
these men, healthcare professionals may be doing a disservice by not equipping them
with genetic education to help them best plan for their future children.
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2.5.3 Considerations for the Future of APA Counseling
More than half of respondents favored potential future testing options to screen
for conditions that have been associated with APA. Their reasons for favoring testing
reflect the influence this type of information would have on their decision-making
processes during pregnancy and their care planning for their child after birth. These
results suggest that the development of prenatal screening techniques for conditions
associated with APA would be favored among these patients and partners and indicate a
potential future direction for these technologies.
Additionally, there may be considerations for the development and application of
a couple-centered strategy counseling on age-related genetic risks. Nearly half of
respondents were in favor of having risk estimates presented as a combined couple’s
assessment; over 40% favored being told each parent’s age-related contribution to the
overall risk. When these findings are partnered with the “new understanding” of what
defines a fully-informed APA patient, providing counseling to the patient on her own
may prove to be an inadequate service in future prenatal genetic counseling sessions, as
men of APA must also be educated about genetic risks associated with their ages. For
female patients whose APA partners are not present for genetic counseling, even though
he may be referred, a potential counseling model can be adapted from cancer genetic
counseling, where the patient leads efforts to disseminate a genetic risk assessment to
appropriate parties with the facilitation of the genetic counselor.
2.5.3 Study Limitations
The sample size in this study was small, and with all participants having received
counseling in a single geographic region, the opinions and preferences of our participants
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are not representative of all advanced parental age couples. All participants were highly
educated and are not representative of the general population seen in many prenatal
clinics. The limited number of eligible men participating in this study further emphasizes
the discrepancy between the genders in who typically attends prenatal genetic counseling
sessions. This portrayal of unavailability of fathers to present for prenatal counseling
represents an additional challenge in considering male referrals to genetic counseling
specifically for APA.
Additionally, the answers provided by participants may not reflect the actions
they would take were they in the described situations. A final recognized limitation was
that, after reviewing respondents’ surveys, some questions may have been worded poorly
so that their meaning was misconstrued by subjects. Furthermore, this study was
designed as a preliminary approach to address several different aspects of counseling that
would contribute to APA pregnancy care, without exploring any area extensively.
2.5.4 Directions for Future Research
Future clinical research needs to make a concerted effort to address the issues
discussed in this study. For instance, analysis could be conducted on the impact of health
literacy and numeracy on decision making in prenatal genetic counseling sessions. Other
research could be conducted to better understand the role of couple dynamics in prenatal
decision making and the feasibility of applying a couple’s counseling model in scenarios
of advanced parental age. Future technological research could focus on the potential
development of screening options for conditions related to APA to equip patients with
better tools than ultrasound in making decisions about pregnancy care. The aim of
research will need to be the collection of reliable information that can used to open the
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possibility of the clinical utility of APA counseling. In turn, these efforts will promote
the development of effective societal guidelines and the education of genetic counselors,
which will translate clinically into fully informed patients and couples who are better able
to make truly informed decisions regarding APA risks.
2.5.5 Practice Implications for Genetic Counseling
There is a concerning gap between the knowledge of APA-associated risks and
mechanisms and current genetic counseling procedure. In addition, the current AMAbased counseling model is inadequate to fully inform patients regarding the risks under
the umbrella of advanced parental age. Our results demonstrate that female patients and
their partners expect more from their counselors, and it is time we start meeting their
expectations. Genetic counselors must begin strategizing ways to address these
shortcomings. We encourage a collaborative effort among representatives of NSGC,
ACMG, and ACOG to address the current deficiencies in this aspect of prenatal protocols
through the composition of updated guidelines that are informed and are malleable to
accommodate future developments in prenatal genetic screening techniques that we may
provide higher quality care for men of APA and their partners.
2.6 Conclusions
The purpose of this study was to highlight developments in the understanding of
APA-related pregnancy risks, to reflect upon the current shortcomings in prenatal genetic
counseling practice regarding APA risks, and to promote the development of updated
counseling protocols based upon the educational and decision-making preferences of
patients and their partners. Our findings support a necessary address to present
procedures within prenatal genetic counseling. We support a revisit of the 2008 ACMG
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guidelines concerning APA as well as research efforts directed toward the future goal of
providing inclusive genetic counseling not only to benefit women of AMA but also men
of APA and the children of these fathers.
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Chapter 3: Conclusions
The purpose of this study was to highlight developments in the understanding of APArelated pregnancy risks, to reflect upon the current shortcomings in prenatal genetic
counseling practice regarding APA risks, and to promote the development of updated
counseling protocols based upon the educational and decision-making preferences of
patients and their partners. Our findings support a necessary address to present
procedures within prenatal genetic counseling. We support a revisit of the 2008 ACMG
guidelines concerning APA as well as research efforts directed toward the future goal of
providing inclusive genetic counseling not only to benefit women of AMA but also men
of APA and the children of these fathers.
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Appendix A – Participant Materials
Please, do NOT write your name on this survey. There is a section at the end for
your contact information if you would like to be included in the drawing. If there is
a question you do not wish to answer, please skip it and continue with the rest of
the survey.
Part A: This section talks about the ages of parents and possible conditions in
pregnancy and in children. Check the box you believe is correct for each sentence.
1. Which parent’s genetic information has a stronger effect on the chance of having a baby
with Down syndrome?

□ Mother

□ Father

□ Equal

□ Neither Parent

2. Which parent’s environment (factors other than genes) has a stronger effect on the
chance of having a baby with Down syndrome?

□ Mother

□ Father

□ Equal

□ Neither Parent

3. A baby’s chance of having Down syndrome is increased only by genetic information from
the parents. A parent’s environment does not increase the chance of Down syndrome.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree

□ Agree

□ Strongly
Agree

4. When a mother is 35 or older at pregnancy, her chance to have a baby with Down
syndrome is higher than a younger mother’s chance.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree

□ Agree

□ Strongly
Agree

5. When a father is older than 40 when his partner is pregnant, his chance to have a baby
with Down syndrome is higher than a younger father’s chance.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree

□ Agree

□ Strongly
Agree

6. The older a mother is, the lower is her chance to have a child with autism.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree
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□ Agree

□ Strongly
Agree

7. The older a father is, the lower is his chance to have a child with autism.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree

□ Agree

□ Strongly
Agree

Part B: This section talks about making genetic testing decisions during pregnancy.
Genetic testing options include screening tests, such as ultrasound or blood tests,
and diagnostic tests, such as amniocentesis or CVS. Check one box for each
statement to show if you agree or disagree with each sentence.
1. The mother should make the final decision about genetic testing options for pregnancy.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree

□ Agree

□ Strongly
Agree

2. The father should make the final decision on genetic testing options for pregnancy.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree

□ Agree

□ Strongly
Agree

3. The doctor should make the final decision about genetic testing options for a patient’s
pregnancy.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree

□ Agree

□ Strongly
Agree

4. The genetic counselor should make the final decision about genetic testing options for a
patient’s pregnancy.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree

□ Agree

□ Strongly
Agree

5. The parents should make the final decision together on genetic testing options for the
pregnancy by agreeing on one option.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree

□ Agree

□ Strongly
Agree

6. Do you think you and your partner would have different opinions on what genetic testing
should be done during pregnancy?
□ Yes

□ No
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7. If you and your partner disagreed on the decision about genetic testing options, who do
you think should make the final decision? Please put these in order from the MOST
important person to make the final decision (1) to the LEAST important person to make
the final decision (4) about genetic testing.
__________
__________
__________
__________

Doctor
Mother of the Baby
Genetic Counselor
Father of the Baby

Part C: Please answer the next three questions with your opinions about this
statement:
Some genetic conditions are related to a parent’s age and cannot be tested for
during pregnancy at the current time.
1. I would still want to know about any genetic risks for my baby related to parents’ ages,
even if tests are not available.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree

□ Agree

□ Strongly
Agree

2. Parents should be informed about all genetic risks related to the mother’s age, even if
testing is not available for every condition.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree

□ Agree

□ Strongly
Agree

3. Parents should be informed about all genetic risks related to the father’s age, even if
testing is not available for every condition.
□ Strongly
Disagree

□ Disagree

□ Neither Agree
nor Disagree

□ Agree

□ Strongly
Agree

4. Doctors and counselors can tell you about health risks for pregnancy in different ways.
One way is to talk about a risk number from the mother and then a risk number from the
father. Another way is to combine the couple’s estimate of risk together. Which would
you rather hear?
□ Two separate risk numbers based on each parent
□ One combined risk number for the couple
Part D: This set of questions asks about how you like to hear numbers about health
risks.
1. The options below are different ways of stating the same risk number. Imagine you are
talking to a doctor about your child’s health risks. Which option from the list below do you
most easily understand and would want the doctor to use?
□
□
□
□

10% chance
1/10 chance
1 chance in 10
10 chances out of 100
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2. Imagine there is a chance your child might be born with a serious condition such as a heart
condition. How would you want the doctor to present this information to you?
□ 1 chance in 10 of having the condition, and 9 chances out of 10 of NOT having the
condition
□ 1/10 chance of having the condition, and 9/10 chance of NOT having the condition
□ 10% chance of having the condition, and 90% chance of NOT having the condition
□ 10 chances out of 100 of having the condition, and 90 chances out of 100 of NOT
having the condition
3. Of your answers to these two questions, which do you like better?
□ Answer from Question #1

□ Answer from Question #2

Part E: Read the following situations about possible future genetic testing options
for pregnancy. Please explain why you would or would not want to have the testing
done.
1. A genetic counselor explains during a future pregnancy that your baby may be at a higher
risk for autism due to a parent’s age. The counselor tells you about a new blood test for
pregnant mothers that can detect genes related to autism. The mother’s blood test could
be done to find out if the baby will have autism. If you (or your partner) were pregnant
and heard this information, would you choose this test in your future pregnancy?
□ Yes

□ No

□ I don’t know

Why did you choose that answer?

_____________________________________________________________________
_____________________________________________________________________
2. Your doctor tells you that the child you are expecting may develop epilepsy (seizures) by
the time he or she is a teenager. Your doctor offers a new scanning test that can tell if
your child is at a higher risk or a lower risk for seizures. Would you choose this test in
your future pregnancy?
□ Yes
□ No
□ I don’t know
Why did you choose that answer?

_____________________________________________________________________
_____________________________________________________________________
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3. A genetic counselor tells you about a mother’s blood test during pregnancy that can detect
certain learning problems that would require special school plans for a child to succeed. If
you (or your partner) were pregnant and heard this information, would you choose this
test in your future pregnancy?
□ Yes

□ No

□ I don’t know

Why did you choose that answer?

_____________________________________________________________________
_____________________________________________________________________
4. For some genetic conditions, ultrasound imaging during pregnancy might be the only
screening test available to you. This may include possible genetic risks in the baby related
to the ages of the mother or the father. The genetic counselor tells you in a future
pregnancy that all of these conditions can be explained to you before your ultrasound is
started. If she counseled you after your ultrasound, she would only explain a specific
condition your child is at higher risk for based on the ultrasound. When would you want to
hear this information?
□ I would want to hear about every risk to the baby before the ultrasound is done.
□ I would only want to hear about a specific risk to the baby after the ultrasound if the
doctor sees something of concern on the ultrasound.
Why would you make that decision?
_____________________________________________________________________
_____________________________________________________________________
Other answers or thoughts you might have about this question:
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
Part F: Please answer the following questions about yourself.
What is your age? ________________
What is your gender?

□ Male

□ Female

What is your highest level of schooling?
□ Did not finish high school
□ Finished high school or GED
□ Some college education

□ Associate’s Degree
□ Bachelor’s Degree
□ College beyond Bachelor’s degree
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With which ethnicity do you best identify?
□ Asian
□ Native American
□ Black
□ White
□ Hispanic
□ Other (please specify): ________________
What is your marital status?
□ Single/Never Married
□ Married
□ Widowed
□ With a Partner

□ Separated
□ Divorced
□ Remarried

Do you have children outside of any current pregnancy?

□ Yes

□ No

How many do you have (including any current pregnancy)? _____________
If you do not have children today, do you hope to have children someday?

□ Yes

□ No

------------------------------------------- End of Survey --------------------------------------------Thank you very much for taking the time to help with our study. Your answers will
help us continue to provide the best care possible for our patients.
When you have completed the survey, please mail it back to us using the postagepaid envelope provided. If you have any questions about the study or the topics in
this survey, please email Andrew Gunter (atgunter@gmail.com) or contact my
advisor, Peggy Walker, Genetic Counselor, at Peggy.Walker@uscmed.sc.edu
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Optional: If you would like to be entered into a drawing for a $25 gift card to a
local restaurant or store, please provide the following contact information. Any
information will be used only to contact winners of the drawing. This page will be
separated from your survey as soon as we open the envelope from you. Contact
information will not be connected with your survey answers and will not be used for
any other purpose.

Name: _____________________________________ (First and Last Names)
Preferred Phone Number: ______________________
Mailing Address: __________________________________ (Number and Street)
__________________________________ (City, State, ZIP)
Email Address (optional): _____________________________________
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University of South Carolina School of Medicine
USC Genetic Counseling Program
Dear Potential Participant:
You are invited to take part in a graduate research study focusing on pregnancy risks
related to older parents’ ages. I am a graduate student in the genetic counseling program at
the University of South Carolina School of Medicine. My research looks at what patients and
their partners understand about genetics issues and also how a couple makes decisions
about pregnancy care. The research involves taking a survey that is included in the packet
given to you. Each survey is meant to be filled out individually, either by a patient or her
partner.
The survey asks your opinions about how you interpret and use numbers, how you
understand some basic genetic principles, and how you make decisions about your
pregnancy care. If you do not wish to answer a certain question, please skip that question
and continue with the rest of the survey.
All responses from the surveys will be kept anonymous and confidential. Please do not
write your name on the survey. The results of this study might be published or presented
at scientific meetings; however, your answers will not be identified in any way. The survey
should take about 15-20 minutes to complete.
As a thank-you for doing our study, you may be entered into a drawing to win a $25 gift card
to a local restaurant or store. You are eligible for the prize whether or not you complete the
survey. If you would like to be entered for the drawing, please fill out your contact info on
the provided last page of packet; packets may be returned before leaving the office or by
mailing using the postage-paid envelope in the packet. If your name is chosen, this prize
will be sent to you at a later date, after the study is done. Your contact information will not
be used for any other purposes besides sending you the gift card if your name is drawn.
Your participation in this research is voluntary. By completing the survey, you are
consenting that you have read and understand this information. At any time, you may
withdraw from the study by not completing the survey.
Thank you for your time and consideration for taking part in this study. Your answers may
help genetic counselors provide the best care for patients and their partners. If you have
any questions about this research, you may contact either me or my faculty adviser, Peggy
Walker, MS, CGC, at the information below. If you have any questions about your rights as a
research member, you may contact the Office of Research Compliance at the University of
South Carolina at (803)777-7095.
Sincerely,
Andrew Gunter, BS, BA
Master of Science Candidate
USC School of Medicine
USC Genetic Counseling Program
Two Medical Park, Suite 208

Peggy Walker, MS, CGC
Faculty Adviser
USC School of Medicine
USC Genetic Counseling Program
Two Medical Park, Suite 208
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Columbia, SC 29203
atgunter@gmail.com
(803) 341-2808

Columbia, SC 29203
Peggy.Walker@uscmed.sc.edu
(803) 545-5746
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